Corbus Pharmaceuticals Holdings, Inc. (CRBP)

CRBP Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0	0	0.88	3.94	36.14
Revenue Growth (YoY)	-	-	-77.61%	-89.11%	649.51%
Gross Profit	0	0	0.88	3.94	36.14
Selling, General & Admin	13.91	18.7	20.43	28.48	23.64
Research & Development	31.17	16.14	36.45	98.27	89.6
Other Operating Expenses	0	5	0	0	0
Operating Expenses	45.08	39.84	56.87	126.75	113.25
Operating Income	-45.08	-39.84	-55.99	-122.81	-77.1
Interest Expense / Income	2.92	2.13	1.83	1.03	-1.23
Other Expense / Income	-3.4	0.38	-12.18	-12.57	-4.42
Pretax Income	-44.6	-42.35	-45.64	-111.27	-71.45
Net Income	-44.6	-42.35	-45.64	-111.27	-71.45
Shares Outstanding (Basic)	4	4	4	3	2
Shares Outstanding (Diluted)	4	4	4	3	2
Shares Change	3.76%	1.85%	57.23%	22.28%	12.10%
EPS (Basic)	-10.31	-10.15	-11.15	-42.60	-33.60
EPS (Diluted)	-10.31	-10.15	-11.15	-42.60	-33.60
Free Cash Flow	-36.1	-37.55	-48.21	-100.17	-48.46
Free Cash Flow Per Share	-8.34	-9.00	-11.77	-38.46	-22.75
Gross Margin	-	-	100.00%	100.00%	100.00%
Operating Margin	-	-	-6350.09%	-3119.20%	-213.33%
Profit Margin	-	-	-5176.38%	-2826.08%	-197.69%
Free Cash Flow Margin	-	-	-5468.27%	-2544.18%	-134.09%
EBITDA	-41.04	-39.45	-42.17	-108.55	-71.45
EBITDA Margin	-	-	-4782.86%	-2756.93%	-197.69%
Depreciation & Amortization	0.64	0.76	1.64	1.69	1.23
EBIT	-41.68	-40.21	-43.81	-110.24	-72.68
EBIT Margin	-	-	-4968.78%	-2799.96%	-201.09%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).